This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Béatrix Reynaud-Mendel, MD
Service de Dermatologie Hôpital St Louis 1 Av Claude Vellefaux 75010 Paris, France

Caroline Robert, MD; Béatrice Flageul, MD; Marie-Christine de Vernejoul, MD; Olivier Verola, MD; Louis Dubertret, MD
Paris

Arch Dermatol. 1997;133(1):113.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Hypercalcemia associated with cancer can result from osteolytic metastases, but in most cases hypercalcemia results from tumoral secretion of a parathyroid hormone—related protein (PTHRP), an analogue of the parathyroid hormone purified recently.¹ Squamous cell carcinoma (SCC) of the lung and oral cavity and breast adenocarcinoma are the most common causes of this paraneoplastic syndrome, also called humoral hypercalcemia of malignancy (HHM).

We report the first case, to our knowledge, of HHM associated with an extensive metastatic cutaneous SCC.

Report of a Case.

A 53-year-old man presented with a voluminous ulcerated tumor of the upper back, which had developed over a 15-year period (Figure). Large axillary lymph nodes appeared 3 years prior to our examination. A complete blood count showed hyperleukocytosis and thrombocytosis. Results of renal and liver function tests and human immunodeficiency virus type 1 and 2 serologic tests were normal or negative. Severe hypercalcemia was present at calcium . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?